• $667,148.00
    Market Cap
  • -9.09%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
09/30/2022
09/30/2021
09/30/2020
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
1.1M
+48.04%
744,064
+53.18%
485,756
N/A
Operating Profit
-1.1M
+48.04%
-744,064
+53.18%
-485,756
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
-298,942
N/A
Interest Income and Expense and Net
0
N/A
0
+100.00%
-298,942
N/A
Total Nonoperating Income and Expense
225,988
+105.97%
-3.8M
+89.71%
-2.0M
N/A
Income before Taxes
-875,478
-80.68%
-4.5M
+82.55%
-2.5M
N/A
Income Taxes
0
N/A
0
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-875,505
-80.68%
-4.5M
+85.91%
-2.4M
N/A
Net Income from Continuing Operations Applicable to Common
-875,505
-80.68%
-4.5M
+82.56%
-2.5M
N/A
Basic EPS and Net Income
N/A
N/A
-0.02
-33.33%
-0.03
N/A
Diluted EPS and Net Income
N/A
N/A
-0.02
-33.33%
-0.03
N/A
Basic Weighted Average Shares
403.7M
+37.46%
293.7M
+257.86%
82.1M
N/A
Diluted Weighted Average Shares
403.7M
+37.46%
293.7M
+257.86%
82.1M
N/A
Balance Sheet
Cash and Cash Equivalents
8,016
-68.32%
25,300
+107.45%
12,196
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
8,016
-68.32%
25,300
+107.45%
12,196
N/A
Total Current Assets
8,016
-68.32%
25,300
-90.50%
266,245
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
208,971
-43.99%
373,081
+40.13%
266,245
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
861,030
+8.19%
795,853
-33.12%
1.2M
N/A
Total Current Liabilities
1.9M
-5.64%
2.0M
-36.01%
3.2M
N/A
Total Long-Term Debt
119,473
+50.53%
79,366
+137.08%
33,476
N/A
Total Long-Term Liabilities
0
N/A
0
-100.00%
30,028
N/A
Total Liabilities
2.0M
-1.65%
2.1M
-35.45%
3.2M
N/A
Retained Earnings
-12.6M
+7.48%
-11.7M
+63.23%
-7.2M
N/A
Total Stockholders Equity
-1.8M
+7.68%
-1.7M
-41.38%
-2.9M
N/A
Total Shares Outstanding
442.3M
+16.03%
381.2M
+297.86%
95.8M
N/A
Cash Flow
Cash from Operating Activities
-426,568
+106.99%
-206,081
-66.08%
-607,634
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
196,127
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
313,708
+21.83%
257,498
-54.23%
562,620
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-300.83%
-78.78%
-1,417.81%
+160.70%
-543.85%
N/A
Return on Equity
49.81%
-74.83%
197.90%
+51.02%
131.04%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.004
-66.40%
0.01
-85.14%
0.08
N/A
Cash Ratio
0.004
-66.40%
0.01
+220.51%
0.004
N/A
Debt-to-Equity Ratio
-0.54
+4.04%
-0.52
+22.04%
-0.42
N/A
Debt-to-Assets Ratio
4.69
+100.01%
2.35
-48.95%
4.60
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow